Public Company News

MINISO to Acquire Stake in Yonghui Superstores, a Leading Chinese Retailer

GUANGZHOU, China, Sept. 23, 2024 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO", "MINISO Group" or the "Company"), a global value retailer offering a variety of trendy lifestyle products featuring IP design, today announced that it has entered into share purchase ...

2024-09-23 20:00 4787

Sercomm Unlocks Deployment Flexibility for Cost-effective Fiber Expansion

Sercomm's I-TEMP 10G PON SFP+ ONU is Now Certified with Harmonic's cOS PON OLT Portfolio ATLANTA, Sept. 23, 2024 /PRNewswire/ -- Sercomm Corporation (TWSE: 5388), a leading provider of telecom and broadband equipment, is pleased to announce the certification of its I-TEMP 10G SFP+ ONU for XGS-PO...

2024-09-23 19:00 3386

WuXi Biologics Included in Hang Seng ESG 50 Index

HONG KONG, Sept. 23, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has been included in the Hang Seng ESG 50 Index, making it the only pharmaceutical company selected this...

2024-09-23 17:30 2334

Uxin Reports Unaudited First Quarter of Fiscal Year 2025 Financial Results

BEIJING, Sept. 23, 2024 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN),China's leading used car retailer, today announced its unaudited financial results for the first quarter endedJune 30, 2024. Highlights for the Quarter Ended June 30, 2024 * Transaction volume was 5,6...

2024-09-23 16:34 4228

SK hynix Applies CXL Optimization Solution to Linux

* HMSDK, a proprietary memory control solution lauded for its performance, is now available on Linux, the world's largest open source operating system * HMSDK optimizes performance between heterogeneous memories, increasing bandwidth by 30% and performance by over 12% * The company will fost...

2024-09-23 08:00 2271

Meihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial Results

YANGZHOU, China, Sept. 20, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries inChina, today reported its unaudited ...

2024-09-21 05:30 7825

Eoptolink Releases OSFP 1.6T DR8 and 2FR4 Series Transceivers for AI/ML Clusters and Cloud Datacenter Networks

CHENGDU, China, Sept. 20, 2024 /PRNewswire/ -- Eoptolink Technology Inc., Ltd. (SZSE: 300502), a leading innovator and provider of advanced optical transceiver solutions, announces the release of its OSFP 1.6T DR8/DR8-2 and 2xFR4 transceivers enabling the next generation high bandwidth networks f...

2024-09-20 13:30 2570

Xiao-I Corporation Renews and Expands Partnership with Inner Mongolia Yili, Transitioning to Subscription-Based Model for AI Services

SHANGHAI, Sept. 19, 2024 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI) ("Xiao-I" or the "Company"), a leading artificial intelligence company, today announced the renewal of its contract with Inner Mongolia Yili Industrial Group Co., Ltd. ("Yili") (A Share:600887). This renewal continues a lo...

2024-09-19 21:45 3173

WiMi Developed a Blockchain-Based Integrated Architecture for Security Maintenance in Cloud Computing

BEIJING, Sept. 19, 2024 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it integrated cloud computing and blockchain technology, and developed a blockchain-based integra...

2024-09-19 21:30 5669

Nuzee, Inc. Announces Endorsement Agreement Between Macanuoli and Five Sports Champions

VISTA, Calif., Sept. 19, 2024 /PRNewswire/ -- NUZEE, INC., ("NUZEE"or the "Company") (NASDAQ:NUZE) a Company with a heritage in specialty coffee and an emerging business in broader consumer food and beverage products, today announced that the Company has signed an endorsement agreement with five ...

2024-09-19 20:30 5587

"BLEACH Soul Puzzle" Launches Worldwide on September 24, 2024 as the First Puzzle Game Based on the BLEACH TV Animation Series

TOKYO, Sept. 19, 2024 /PRNewswire/ -- KLab Inc., a leader in online mobile games, announced that the first puzzle game based on the hit TV animation series BLEACH,BLEACH Soul Puzzle, is set for a worldwide release on Tuesday, September 24, 2024. (Support is provided for English and Japanese.) See...

2024-09-19 14:10 2557

Best Poster of ESMO 2024! Abbisko Announces Updated Clinical Data of Irpagratinib in HCC

SHANGHAI, Sept. 18, 2024 /PRNewswire/ -- Abbisko Therapeutics (HKEX: 02256) is excited to announce the receipt of the ESMO 2024 Best Poster Award on September 16, 2024. The award was received for the presentation titled "Updated Safety and Efficacy of Irpagratinib (ABSK011) in advanced hepatocell...

2024-09-19 09:00 6020

Uxin to Report First Quarter Fiscal Year 2025 Financial Results on September 23, 2024

BEIJING, Sept. 18, 2024 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN),China's leading used car retailer, today announced that it will release its unaudited financial results for the first quarter of fiscal year 2025 endedJune 30, 2024, before the U.S. market opens on Septe...

2024-09-18 17:00 4460

Maitong Sunshine Cultural Begins Trading on the OTC Markets

NEW YORK, Sept. 18, 2024 /PRNewswire/ -- Maitong Sunshine Cultural Development Co., Limited (OTC Markets: MGSD, the "Company") today announced that the Company begins trading on the OTC Markets. The Company is a professional enterprise that provides cultural and tourism services with distinctive ...

2024-09-18 16:30 4169

Senhwa Biosciences Announces IND Submission to US FDA for Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors sponsored by NCI

TAIPEI and SAN DIEGO, Sept. 17, 2024 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), , a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that an Investigational New Drug (IND) application for Pidnarulex ...

2024-09-18 10:06 2853

Breakthrough in Long COVID: An investigator-initiated trial (IIT) with Hyundai Bioscience's Xafty by UCSD

SAN DIEGO, Sept. 17, 2024 /PRNewswire/ -- Hyundai Bioscience USA announced that it has signed an MOU with theUniversity of California San Diego (UCSD) to conduct an investigator-initiated trial to evaluate the efficacy of Xafty®, a niclosamide-based antiviral developed by its Korean headquarters,...

2024-09-18 09:26 3639

XCharge, Asia Green Fund's Portfolio, Successfully Listed on Nasdaq

BEIJING, Sept. 14, 2024 /PRNewswire/ -- XCHG Limited (XCHARGE) (NASDAQ: XCH) announced the pricing of its initial public offering. XCharge, founded in 2015, is a global leader in integrated EV charging solutions, focusing on Innovative New Energy Technologies and Sustainable Development . The Co...

2024-09-18 09:22 2824

Mega Matrix Announces That the Short Drama "Revenge Beyond the Grave", Will Be Released on September 18 at FlexTV

PALO ALTO, Calif., Sept. 17, 2024 /PRNewswire/ --  Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU), today announced that it will launch its revenge short drama "Revenge Beyond the Grave" onSeptember 18th at FlexTV.  This is no ordinary tale of vengeance, as it delves deeper into t...

2024-09-18 00:49 2644

Datasea's New 5G AI Multimodal Agreements Have Already Generated $9.0 Million of 5G-AI Services

Agreements Boost Fiscal 2025 Revenue and Expand Datasea's 5G Application Market Positioning inChina BEIJING, Sept. 17, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada-based company focused on innovative high-tech acoustics and 5G-Artificial Intelligence ("A...

2024-09-17 21:45 2499

Subgroup Analysis from Pivotal WU-KONG1B Study Exhibits Robust Efficacy of Sunvozertinib in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations Across Different Baseline Characteristics

Results of subgroup analysis from the pivotal WU-KONG1B study in relapsed or refractory NSCLC with EGFR exon20ins presented at ESMO 2024 * Sunvozertinib demonstrated promising anti-tumor efficacy, regardless of EGFR exon20ins region classification, race, region, baseline brain metastasis, prio...

2024-09-17 15:47 2805
1 ... 226227228229230231232 ... 769

Week's Top Stories